Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 6/20 | 0.47 |
| ▸ | TSHR | P16473 | 5/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.47 |
| ▸ | CA2 | P00918 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | MMP9 | P14780 | 1/20 | 0.38 |
| ▸ | MMP8 | P22894 | 1/20 | 0.38 |
| ▸ | MMP14 | P50281 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.36 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.36 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL101500 | 0.89 | CYP3A4 (0.47) | CYP3A4TSHRTDP1ATML3MBTL1 | |
| SCHEMBL978998 | 0.84 | ALDH1A1 (0.50) | CYP3A4TSHRTDP1ATML3MBTL1 | |
| SCHEMBL10498392 | 0.83 | CYP3A4 (0.46) | CYP3A4TSHRTDP1ATML3MBTL1 | |
| SCHEMBL815687 | 0.83 | CYP3A4 (0.46) | CYP3A4TSHRTDP1ATML3MBTL1 | |
| SCHEMBL8217861 | 0.82 | ALDH1A1 (0.52) | CYP3A4TSHRTDP1ATML3MBTL1 | |
| SCHEMBL4575273 | 0.81 | ALDH1A1 (0.53) | CYP3A4TSHRTDP1ATML3MBTL1 | |
| SCHEMBL28477060 | 0.81 | CYP3A4 (0.47) | CYP3A4TSHRTDP1ATML3MBTL1 | |
| SCHEMBL6683323 | 0.80 | CYP3A4 (0.50) | CYP3A4TSHRTDP1ATML3MBTL1 | |
| SCHEMBL6248707 | 0.80 | ALDH1A1 (0.50) | CYP3A4TSHRTDP1ATML3MBTL1 | |
| SCHEMBL2818214 | 0.79 | CYP3A4 (0.53) | CYP3A4TSHRTDP1ATML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120088698-A1 | WATER IN OIL EMULSION, METHOD FOR THE PRODUCTION THEREOF | CLARIANT FINANCE (BVI) LIMITED (VG) | 2012-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120088698-A1 | WATER IN OIL EMULSION, METHOD FOR THE PRODUCTION THEREOF | H1-0, H1-3, H1-2 | CYP3A4 3420/4885TSHR 2697/4885TDP1 4163/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.